广东
分享至
智通财经APP讯，复星医药(600196.SH)公告，公司境外控股子公司Gland Pharma拟以自有闲置资金投资印度当地共同基金及/或债券(政府或企业债券)，单日最高投资余额不超过等值印度卢比200亿元。单笔投资不超过12个月。
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
